The American Heart Association/American Stroke Association demonstrated that Lp-PLA2 measurements are useful in predicting which patients are at higher risk of stroke (5), and the European Society of Cardiology recommended Lp-PLA2 as a predictor of increased risk for a recurrent acute atherothrombotic event (6). The gene discussed is PLA2G7; the disease is stroke disorder.